Skip to main content

Table 2 Summary of clinical characteristics between 2 CF groups age ≤18 years and >18 years with Candida dubliniensis

From: Persistence of Candida dubliniensis and lung function in patients with cystic fibrosis

Parameters

≤18 years (N = 18)

>18 years (N = 11)

P

N(%)

N(%)

Sex/male

10 (55.6)

7 (63.6)

0.668

No. of CF patients with CFTR 1234 V mutation

18 (100)

11 (100)

 

No. of CF patients with pancreatic sufficiency

18 (100)

10 (90.9)

0.193

No. of CF patients with CF related diabetes

0 (0)

4 (36.4)

0.014

Nebulized Tobramycin use

7 (38.9)

8 (72.7)

0.077

Oral zythromax use

0 (0)

6 (54.5)

0.001

Nebulized pulmozyme use

12 (66.7)

10 (90.9)

0.139

Nebulized hypertonic saline use

5 (27.8)

6 (54.5)

0.149